OBJECTIVE: Through a hospital-based SARS-CoV-2 molecular and serological screening, we evaluated the effectiveness of two months of lockdown and two of surveillance, in Milan, Lombardy, the first to be overwhelmed by COVID-19 pandemics during March-April 2020. METHODS: All subjects presenting at the major hospital of Milan from May-11 to July-5, 2020, underwent a serological screening by chemiluminescent assays. Those admitted were further tested by RT-PCR. RESULTS: The cumulative anti-N IgG seroprevalence in the 2753 subjects analyzed was of 5.1% (95%CI = 4.3%-6.0%), with a peak of 8.4% (6.1%-11.4%) 60-63 days since the peak of diagnoses (March-20). 31/106 (29.2%) anti-N reactive subjects had anti-S1/S2 titers >80 AU/mL. Being tested from May-18 to June-5, or residing in the provinces with higher SARS-CoV-2 circulation, were positively and independently associated with anti-N IgG reactivity (OR [95%CI]: 2.179[1.455-3.264] and 3.127[1.18-8.29], respectively). In the 18 RT-PCR positive, symptomatic subjects, anti-N seroprevalence was 33.3% (95% CI: 14.8%-56.3%). CONCLUSION: SARS-CoV-2 seroprevalence in Milan is low, and in a downward trend after only 60-63 days since the peak of diagnoses. Italian confinement measures were effective, but the risk of contagion remains concrete. In hospital-settings, the performance of molecular and serological screenings upon admission remains highly advisable.
OBJECTIVE: Through a hospital-based SARS-CoV-2 molecular and serological screening, we evaluated the effectiveness of two months of lockdown and two of surveillance, in Milan, Lombardy, the first to be overwhelmed by COVID-19 pandemics during March-April 2020. METHODS: All subjects presenting at the major hospital of Milan from May-11 to July-5, 2020, underwent a serological screening by chemiluminescent assays. Those admitted were further tested by RT-PCR. RESULTS: The cumulative anti-N IgG seroprevalence in the 2753 subjects analyzed was of 5.1% (95%CI = 4.3%-6.0%), with a peak of 8.4% (6.1%-11.4%) 60-63 days since the peak of diagnoses (March-20). 31/106 (29.2%) anti-N reactive subjects had anti-S1/S2 titers >80 AU/mL. Being tested from May-18 to June-5, or residing in the provinces with higher SARS-CoV-2 circulation, were positively and independently associated with anti-N IgG reactivity (OR [95%CI]: 2.179[1.455-3.264] and 3.127[1.18-8.29], respectively). In the 18 RT-PCR positive, symptomatic subjects, anti-N seroprevalence was 33.3% (95% CI: 14.8%-56.3%). CONCLUSION:SARS-CoV-2 seroprevalence in Milan is low, and in a downward trend after only 60-63 days since the peak of diagnoses. Italian confinement measures were effective, but the risk of contagion remains concrete. In hospital-settings, the performance of molecular and serological screenings upon admission remains highly advisable.
Authors: Yee-Joo Tan; Phuay-Yee Goh; Burtram C Fielding; Shuo Shen; Chih-Fong Chou; Jian-Lin Fu; Hoe Nam Leong; Yee Sin Leo; Eng Eong Ooi; Ai Ee Ling; Seng Gee Lim; Wanjin Hong Journal: Clin Diagn Lab Immunol Date: 2004-03
Authors: Andrew Bryan; Gregory Pepper; Mark H Wener; Susan L Fink; Chihiro Morishima; Anu Chaudhary; Keith R Jerome; Patrick C Mathias; Alexander L Greninger Journal: J Clin Microbiol Date: 2020-07-23 Impact factor: 5.948
Authors: Mei San Tang; Karl G Hock; Nicole M Logsdon; Jennifer E Hayes; Ann M Gronowski; Neil W Anderson; Christopher W Farnsworth Journal: Clin Chem Date: 2020-08-01 Impact factor: 8.327
Authors: Kimberly E Hanson; Angela M Caliendo; Cesar A Arias; Janet A Englund; Mark J Lee; Mark Loeb; Robin Patel; Abdallah El Alayli; Mohamad A Kalot; Yngve Falck-Ytter; Valery Lavergne; Rebecca L Morgan; M Hassan Murad; Shahnaz Sultan; Adarsh Bhimraj; Reem A Mustafa Journal: Clin Infect Dis Date: 2020-06-16 Impact factor: 9.079
Authors: K L Chew; S S Tan; S Saw; A Pajarillaga; S Zaine; C Khoo; W Wang; P Tambyah; R Jureen; S K Sethi Journal: Clin Microbiol Infect Date: 2020-06-09 Impact factor: 8.067
Authors: Silvano Gallus; Luca Paroni; Dino Re; Riccardo Aiuto; Davide Maria Battaglia; Rolando Crippa; Nicolò Carugo; Matteo Beretta; Lorenzo Balsano; Luigi Paglia Journal: Int J Environ Res Public Health Date: 2021-04-02 Impact factor: 3.390
Authors: Rigan Louis; Ruiyu Pu; Tracey D Logan; Luke Trimmer-Smith; Richard Chamblain; Adriana Gallagher; Valery Madsen Beau De Rochars; Eric Nelson; Derek A T Cummings; Maureen T Long; J Glenn Morris Journal: PLoS One Date: 2022-08-25 Impact factor: 3.752
Authors: Andreas C Chrysostomou; Bram Vrancken; George Koumbaris; George Themistokleous; Antonia Aristokleous; Christina Masia; Christina Eleftheriou; Costakis Iοannou; Dora C Stylianou; Marios Ioannides; Panagiotis Petrou; Vasilis Georgiou; Amalia Hatziyianni; Philippe Lemey; Anne-Mieke Vandamme; Philippos P Patsalis; Leondios G Kostrikis Journal: Viruses Date: 2021-06-09 Impact factor: 5.048